Double jeopardy: Comorbid anxiety and depression in late life

Research in Gerontological Nursing
Elizabeth BeattieSara J Franklin

Abstract

Comorbid depression and anxiety in late life present challenges for geriatric mental health care providers. These challenges include identifying the often complex diagnostic presentations both clinically and in a research context. This potent comorbidity can be conceived as double jeopardy in older adults, further diminishing their quality of life. Geriatric health care providers need to understand psychiatric comorbidity of this type for accurate diagnosis and early referral to specialists, and to coordinate interdisciplinary care. Researchers in the field also need to recognize potential multiple impacts of comorbidities with respect to assessment and treatment domains. This article describes the prevalence of late-life depression and anxiety disorders and reviews studies on this comorbidity in older adults. Risk factors and protective factors for anxiety and depression in later life are reviewed, and information is provided about comparative symptoms, the selection of assessment tools, and challenges to the provision of interdisciplinary, evidence-based care.

References

Jan 1, 1990·International Journal of Psychiatry in Medicine·J M ZichT K Greenfield
Jan 1, 1990·Journal of Psychiatric Research·D A RegierD S Rae
Oct 8, 1988·BMJ : British Medical Journal·D GoldbergD Grayson
Feb 1, 1988·Biological Psychiatry·G S AlexopoulosC A Shamoian
Jun 1, 1987·The Gerontologist·D BlazerL K George
Oct 1, 1972·Journal of Clinical Psychology·W W Zung
Mar 1, 1984·The Journal of Psychology·S Himmelfarb, S A Murrell
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
May 1, 1994·The American Journal of Psychiatry·A J Flint
Jan 1, 1996·International Psychogeriatrics·I Montorio, M Izal
Jan 1, 1997·Behaviour Research and Therapy·T A BrownD H Barlow
Jan 1, 1996·European Archives of Psychiatry and Clinical Neuroscience·I MellerH Schroppel
Jan 1, 1996·Anxiety·B H MulsantM Miller
Mar 13, 1998·Annual Review of Psychology·S MinekaL A Clark
Aug 26, 1999·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L TeriE B Larson
Oct 26, 1999·The British Journal of Psychiatry : the Journal of Mental Science·A T BeekmanM J Prince
Jan 5, 2000·The American Journal of Psychiatry·R E RobertsW J Strawbridge
Jan 5, 2000·The American Journal of Psychiatry·A T BeekmanW van Tilburg
Jun 6, 2000·Archives of General Psychiatry·D C SteffensJ C Breitner
Sep 13, 2000·Clinical Psychology Review·M A Stanley, J G Beck
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Oct 23, 2001·Depression and Anxiety·E J LenzeC F Reynolds
Aug 3, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·Paul NaardingFrans R J Verhey
Aug 17, 2002·Biological Psychiatry·Martha L Bruce
Aug 17, 2002·Biological Psychiatry·K Ranga R Krishnan
Aug 17, 2002·Biological Psychiatry·Patricia A Areán, Beth L Cook
Sep 6, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Lenore H KurlowiczGreg Maislin
Oct 31, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Stephen J BartelsAricca R Dums
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Jürgen UnützerUNKNOWN IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment
Mar 14, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Dan G Blazer
Jun 5, 2003·The American Journal of Psychiatry·Martin G Cole, Nandini Dendukuri
Jan 1, 1965·Archives of General Psychiatry·W W ZUNG
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 1, 2004·The American Journal of Psychiatry·R Michael BagbyMargarita B Marshall

❮ Previous
Next ❯

Citations

Jul 23, 2011·International Psychogeriatrics·Nancy A PachanaAnnette Dobson
Feb 28, 2014·International Psychogeriatrics·Nancy A PachanaLeander K Mitchell
Nov 15, 2014·Global Spine Journal·Mahsa Sedighi, Ali Haghnegahdar
Aug 20, 2019·Clinical Gerontologist·Michael J HughesNancy A Pachana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved